Clayton Dubilier & Rice to acquire a 50% stake in Opella from Sanofi for €8bn.

Clayton Dubilier & Rice, a global investment firm, agreed to acquire a 50% stake in Opella, the consumer healthcare unit of Sanofi, an innovative global healthcare company, for €8bn. "This is an exciting opportunity for CD&R to partner with Sanofi, one of the world’s leading healthcare companies, to support Opella’s ambitious management team as it invests in innovation and growth to create a French-headquartered, global consumer healthcare champion. Opella is differentiated by the quality of its brand portfolio and its highly skilled and motivated workforce. We see significant opportunities to enhance Opella’s market leadership by leveraging our deep industry expertise, broad network of operating talents, and capital resources to position the company for accelerated growth. We look forward to supporting both its French operations, including Opella’s critical manufacturing footprint and advanced R&D capabilities, and further developing its global platform to better serve employees, consumers, and patients," Eric Rouzier, CD&R Partner and Head of European Healthcare.